Natera, Inc. and Kupando Therapeutics Launch Phase 1 Study to Monitor ctDNA in Advanced Skin Cancers
AUSTIN, Texas, August 12, 2026 Natera, Inc. announced a new collaboration with Kupando Therapeutics to support a Phase 1...
Liquid Biopsy
Advertisement
Zepto Life Technology Wins NIAID Contract for FungiFlex
St. Paul, Minnesota, August,11, 2026 Zepto Life Technology has been awarded a contract valued at up to $8.9 million...
Sight Sciences Receives FDA Clearance for OMNI Ultra
Menlo Park, California – August 4, 2026 Sight Sciences, Inc. has announced that the U.S. Food and Drug Administration...
New England Biolabs Launches Monarch Mag cfRNA Extraction Kit
Ipswich, Massachusetts – August 4, 2026 New England Biolabs (NEB®) has expanded its molecular biology portfolio with the launch...
Belay Diagnostics Reports Strong Clinical Utility for Summit 2.0
CHICAGO, July 21, 2026 Belay Diagnostics has announced the publication of a peer-reviewed clinical utility study demonstrating that its...
Advertisements
Plus Therapeutics Secures Medical Mutual Coverage Agreement
Houston, Texas, USA | July 21, 2026 Plus Therapeutics, through its wholly owned subsidiary CNSide Diagnostics, announced a regional...
Haier Biomedical Unveils Digital Blood Management Platform
KUALA LUMPUR, Malaysia, July 21, 2026 Haier Biomedical showcased its next-generation Digital Blood Management Platform at the ISBT Congress...
Tempus to Acquire Personalis in $1.5B Precision Oncology Deal
CHICAGO, July 20, 2026 Tempus AI, Inc. has entered into a definitive agreement to acquire Personalis, Inc. in a...
GRAIL Teams with Priority Health to Expand Galleri
MENLO PARK, Calif., July 16, 2026 GRAIL, Inc. has announced a strategic collaboration with Priority Health, making the Galleri®...
Zepto Life Launches FungiFlex Tests for Rapid Fungal Diagnosis
IRVINE, Calif., July 15, 2026 Zepto Life Technology has expanded its FungiFlex® molecular diagnostics portfolio with the launch of...
Advertisement
